In a recent study [88], the gene coding for brain-derived neurotrophic factor (BDNF) was suggested to be a gene biomarker for depression, thereby providing an alternative route to the early identification of breast cancer patients who can be targeted for therapies against depression, which would result in better outcomes. The gene discussed is BDNF; the disease is breast carcinoma.